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Abstract
Animal studies have shown that shock wave lithotripsy (SWL) delivered with an initial course of 
low-energy shocks followed by a pause reduces renal injury. The pause correlates with increased 
arterial resistive index (RI) during SWL as measured by ultrasound. This suggests that renal 
vasoconstriction is associated with protecting the kidney from injury. This study explored whether 
a similar increase in RI is observed in humans. Patients were prospectively recruited from two 
hospitals. All received an initial dose of 250 lowest energy shocks followed by a two-minute 
pause. Shock power was then ramped up at the discretion of the physician; shock rate was 
maintained at 1 Hz. Spectral Doppler velocity measurements were taken from an interlobar artery 
at baseline after induction, during the pause at 250 shocks, after 750 shocks, after 1500 shocks, 
and at the end of the procedure. RI was calculated from the peak systolic and end diastolic 
velocities and a linear mixed-effects model was used to compare RIs. The statistical model 
accounted for age, gender, laterality, and body mass index (BMI). Measurements were taken from 
15 patients. Average RI ± standard deviation pretreatment, after 250 shocks, after 750 shocks, 
after 1500 shocks, and post treatment was 0.68 ± 0.06, 0.71 ± 0.07, 0.73 ± 0.06, 0.75 ± 0.07 and 
0.75 ± 0.06, respectively. RI was found to be significantly higher after 250 shocks compared to 
pretreatment (p = 0.04). RI did not correlate with age, gender, BMI, or treatment side. This is 
suggestive that allowing a pause for renal vascular vasoconstriction to develop may be beneficial, 
and can be monitored for during SWL, providing real-time feedback as to when the kidney is 
protected.
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I. Introduction
There are approximately 350,000 shock wave lithotripsy (SWL) procedures performed 
annually in the U.S. - the most common surgical treatment for nephrolithiasis [1]. SWL is 
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transcutaneous, minimally invasive, and generally safe. Although complications related to 
the procedure are uncommon, there is a component of acute kidney injury that occurs as a 
result of the high energy shocks. The extent of injury in humans is unknown. The extent of 
acute renal injury in animals though has been evaluated histologically and found to be as 
high as 7.6% of the functional renal volume. The extent of injury was found to be dependent 
on the number of shock waves administered, the pulse amplitude, and the rate of shockwave 
delivery [2–10].
Research in animals focused on reducing shock wave-induced injury determined that the 
loss of functional volume can be reduced by minimizing the total number of shock waves, 
maintaining a shock wave rate of 60 shocks per minute, and slowly increasing the power 
amplitude of the shock waves [11,12]. In particular, initiating treatment with low energy 
shock waves and a pause was shown to eliminate injury in pigs, and has been termed the 
“protection protocol” [5,12,13]. The protection protocol has also been shown to be 
associated with an increase in (pig) renal vascular resistive index (RI) intraoperatively, 
which is not seen in kidneys without the pretreatment [5,14]. Human and pig kidneys have 
been shown to be in a state of vasoconstriction after SWL; only with the protection protocol 
has the RI been shown to have a significant rise during SWL. The supposition is thus that 
vasoconstriction induced by the protocol protects the kidney from injury while the shock 
waves are applied.
Many clinicians have adopted the use of the protection protocol based on the results of the 
animal studies. Yet there are no studies indicating whether the protocol has a benefit in 
humans, or if a change in RI occurs. Our study seeks to evaluate if renal vascular RI 
increases in humans similarly to what has been observed in animal studies.
II. Materials and Methods
A. Study Population
Seventeen patients were prospectively recruited from the University of Washington Medical 
Center and the Puget Sound Veterans Hospital. Inclusion criteria were age > 18 years, a 
radio-opaque renal or ureteral stone planning to undergo SWL. Subjects were excluded if we 
were not able to adequately image the kidney or renal vessel during treatment.
B. Study Protocol
SWL was performed using the Dornier Compact Delta II Lithotripter (Dornier MedTech, 
Munich, Germany) or Lithotron (Healthtronics, Austin TX, USA) with fluoroscopic 
guidance. Patients were treated under general anesthesia at a rate of 60 shocks per minute 
for a minimum of 1500 shocks and a maximum of 2500 shocks. The initial 250 shocks were 
delivered at the lowest power setting and all patients had a two minute pause in treatment 
following delivery of 250 shocks. Treatment power was incrementally increased for the 
remainder of the treatment. The manner in which the power was increased and the total 
number of shocks delivered was at the surgeon’s discretion. The study and protocol was 
approved by the institutional review board of both institutions included in this study.
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RI was calculated from peak systolic and end diastolic velocities measured using Doppler 
ultrasound (Siemens Acuson Sequoia 512, Siemens Medical solutions, Malvern, PA and 
HDI 5000, Phillips, Amsterdam, Netherlands). All measurements were taken from the same 
interlobar renal artery by a sonographer trained in renal imaging. Treatment was briefly 
paused for the measurement. The length of treatment delay was recorded as well as the 
systolic and diastolic blood pressure (from the anesthesia records). Baseline velocity 
measurements were taken prior to the start of SWL, but after induction of general anesthesia 
and coupling of the lithotripter. Subjects were excluded if an adequate baseline RI could not 
be obtained. The velocity measurements were repeated after 250 shocks, 750 shocks, 1500 
shocks, and at the completion of the study, prior to extubation and decoupling of the 
lithotripter.
C. Statistical Model
A linear mixed effects model was used to compare RI across different time points with 
statistical significance defined as p < 0.05. A random intercept was adopted for each subject 
to handle within-subject correlations. Time was included as a categorical variable to account 
for potential nonlinear effects. The same model was used to control for age, gender, BMI, 
side, and intraoperative blood pressure.
III. Results
RI data was collected from fifteen subjects undergoing SWL for renal calculi. This included 
4 female and 11 male subjects, 11 left kidney stones and 4 right kidney stones. Two patients 
were excluded due to an inability to obtain baseline RI. Mean subject age was 61 ± 15 and 
average BMI was 29 ± 5 (Table 1). Average stone size was 11 ± 8 mm, with 5 subjects 
(33%) undergoing treatment of multiple stones in different calyces.
A. Perioperative
Mean operative time from induction of anesthesia to extubation was 82 ± 12 minutes with an 
average procedure time of 46 ± 8 minutes. Mean blood pressure dropped significantly (p < 
0.001) within the first 250 shocks and showed a consistent, but non-significant increase, 
from 250 shocks to the end of treatment (p = 0.19 systolic, p = 0.79 diastolic) (Table 1).
B. Resistive Index
Mean RI rose to a significantly higher level than baseline after delivery of 250 shocks (p = 
0.04) (Table 1) and remained elevated through 750 shocks, 1500 shocks, and post-treatment 
(each p < 0.001 relative to pre-treatment). There was no significant change in RI after 
administration of 750 shocks (p = 0.18), though there was a slight increase in RI throughout 
the procedure (Figures 1 and 2). Treatment delay to measure renal vascular RI was on 
average 66 ± 48 seconds.
On multivariate analysis age, systolic blood pressure, gender, BMI, and renal side were not 
associated with increases in RI. A lower diastolic blood pressure was associated with a 
higher RI (p=0.02). After adjusting for both systolic and diastolic blood pressure, RI became 
significantly higher than pre-treatment RI beginning at 750 (p = 0.05) versus 250 shocks.
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IV. Discussion
SWL is associated with renal injury. Porcine kidney studies have shown this is primarily due 
to the rupture of blood vessels. As an example, standard treatment using a Dornier HM3 
lithotripter delivering 2000 shocks at 120 SW/minute and 24 kV has been shown to result in 
a 5–6% loss of functional renal volume [13]. In humans, the amount of injury due to SWL 
treatment is unknown, though some investigators believe that repeated treatment may lead to 
renal fibrosis and long-term medical complications.
Investigators studying the effects of post-SWL complications have utilized multiple clinical 
parameters including excretory urography, computed tomography, magnetic resonance 
imaging, radionucleotide renography, and renal vascular RI. RI has proven sensitive for 
vascular and tubulointerstitial diseases of the kidney in other clinical settings, with values 
greater than 0.7 often indicative of pathology. Studies evaluating the correlation between 
SWL treatment and renal vascular RI have demonstrated that the majority of patients show a 
significant rise in RI as early as 30 minutes post-treatment, and, in some cases, RI may 
remain elevated for months following treatment [12–14]. While the clinical implications of a 
transient rise in renal vascular RI are unclear, a long-term and persistent rise in RI has been 
implicated in new onset hypertension, particularly for the elderly [15–17]. Knapp et al. 
(1996) found that an RI value surpassing 0.69 was 80% sensitive and 80% specific in 
predicting arterial hypertension in patients who underwent ESWL treatment [17].
These studies suggest that a persistent elevated renal vascular RI post treatment, which is 
indicative of vasoconstriction and decreased renal perfusion, may be associated with renal 
injury. In contrast, animal studies have suggested that an elevated intraoperative RI may be 
renal protective. Results showed that kidneys exposed to a renal-protective protocol had 
reduced functional renal injury (as a result of SWL) by as much as 85% [5,12,13]. Renal 
protection was achieved by an initial administration of four minutes of either low dose 
energy shocks or low dose shocks combined with a treatment pause. In the animal studies, 
both protocols were associated with a significant rise in intraoperative renal RI. Kidneys not 
exposed to this renal-protective protocol showed no changes in renal vascular RI during 
treatment or reduction in functional injury. The authors hypothesized that the intraoperative 
rise in renal vascular RI resulted in decreased effective blood flow to the kidney, leading to a 
reduction in hemorrhage and subsequent decrease in overall renal injury. It is important to 
note that all kidneys treated, regardless of whether they underwent a renal-protective 
protocol or not, had significantly higher post-treatment renal vascular RI compared to pre-
treatment.
Our results in human subjects using a renal-protective SWL protocol show a similar 
response in RI as in the animal studies [5,11–14]. Based on our findings, we believe that an 
elevated renal vascular RI is not solely an indication of renal injury, as is suggested by the 
current literature [15–17]. We believe that an increase in RI early during treatment is 
indicative of a “protected” state, while sustained elevations of RI following treatment may 
predict renal scarring and long-term complications.
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Renal vascular RI is measured with ultrasound and can be performed during SWL treatment 
by a trained specialist. Overall, the additional time required was minimal. We found that the 
pre-treatment measurement of RI took the longest (153 ± 119 seconds), presumably to 
initially locate the kidney and identify an appropriate interlobar artery. Once located, time 
taken to obtain further measurements during active treatment was only 66 ± 48 seconds. 
Furthermore, our study suggests that the main rise renal vascular RI occurs primarily in the 
beginning of treatment, with a large rise by 250 shocks and relative stability of RI by 750 
shocks.
There are limitations to our study. First, we lacked a control group where subjects are 
exposed to SWL without a renal-protective protocol. Animal studies have shown this is 
associated with increased renal injury, which raises ethical concerns. We were also unable to 
obtain renal vascular RI without briefly stopping treatment – i.e. we would introduce a pause 
even in the control group. Our sample size was relatively small and we were unable to 
control for comorbid conditions and medications. Lastly, while we were able to control for 
systemic blood pressure changes, there may have been an additional relationship between 
systemic blood pressure and renal RI that was not controlled for in the included analyses.
V. Conclusion
This paper reports on the first study to demonstrate the effect of a renal protective protocol 
during SWL on intraoperative RI in humans. We found that the increase in renal vascular RI 
parallels animal studies that have demonstrated that an increase in RI during treatment is 
associated with decreased histologic renal injury. Our data support prior research suggesting 
a delay in increasing shock wave energy until after four minutes of pretreatment (with low-
energy shock waves or a brief pause) is sufficient to achieve the renal protection. The use of 
intraoperative monitoring of renal vascular RI may be a valuable tool; we believe that this 
measure can be utilized to determine when a kidney is “protected” and guide treatment. 
Further research is needed to determine the exact role of renal vascular RI in both immediate 
and long-term complications.
Acknowledgments
This work was supported by NIH NIDDK grant DK43881 and the National Space Biomedical Research Institute 
through NASA NCC 9–58.
We acknowledge the help of our collaborators in the Consortium for Shock Waves in Medicine funded by our NIH 
Program Project grant.
VII. References
1. The National Kidney Foundation. http://www.kidney.org/atoz/content/
kidneystones_ShockWave.cfm
2. McAteer J, Evan A. The acute and long-term adverse effects of shock wave lithotripsy. Semin 
Nephrol. Mar.2008 28:200–213. [PubMed: 18359401] 
3. Connors B, Evan A, Blomgren P, Willis L, Handa R, Lifshitz D, et al. Reducing shock number 
dramatically decreases lesion size in a juvenile kidney model. J Endourol. Sep.2006 20:607–611. 
[PubMed: 16999608] 
Bailey et al. Page 5
IEEE Int Ultrason Symp. Author manuscript; available in PMC 2015 July 20.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
4. Connors B, Evan A, Willis L, Blomgren P, Lingeman J, Fineberg N. The effect of discharge voltage 
on renal injury and impairment caused by lithotripsy in the pig. J Am Soc Nephrol. Feb.2000 
11:310–318. [PubMed: 10665938] 
5. Handa R, McAteer J, Connors B, Liu Z, Lingeman J, Evan A. Optimizing an escalating shockwave 
amplitude treatment strategy to protect the kidney from injury during shockwave lithotripsy. BJUI. 
Dec.2012 110:1041–1047.
6. Connors B, Evan A, Blomgren P, Handa R, Willis L, Gao S, et al. Extracorporeal shock wave 
lithotripsy at 60 shock waves/min reduces renal injury in a porcine model. BJUI. Oct.2009 
104:1004–1008.
7. Delius M, Enders G, Xuan Z, Liebich H, Brendel W. Biological effects of shock waves: kidney 
damage by shock waves in dogs--dose dependence. Ultrasound Med Biol. Feb.1988 14:117–122. 
[PubMed: 3347964] 
8. Delius M, Jordan M, Eizenhoefer H, Marlinghaus E, Heine G, Liebich H, et al. Biological effects of 
shock waves: kidney haemorrhage by shock waves in dogs--administration rate dependence. 
Ultrasound Med Biol. Aug.1988 14:689–694. [PubMed: 3212839] 
9. Morris J, Husmann D, Wilson W, Preminger G. Temporal effects of shock wave lithotripsy. J Urol. 
Apr.1991 145:881–883. [PubMed: 1672386] 
10. Willis L, Evan A, Connors B, Blomgren P, Fineberg N, Lingeman J. Relationship between kidney 
size, renal injury, and renal impairment induced by shock wave lithotripsy. J Am Soc Nephrol. 
Aug.1999 10:1753–1762. [PubMed: 10446943] 
11. Willis L, Evan A, Connors B, Handa R, Bomgren P, Lingeman J. Prevention of lithotripsy-induced 
renal injury by pretreating kidneys with low-energy shock waves. JASN. Mar.2006 17:663–673. 
[PubMed: 16452495] 
12. Handa R, Bailey M, Paun M, Gao S, Connors B, Willis L, et al. Pretreatment with low-energy 
shock waves induces renal vasoconstriction during standard shock wave lithotripsy (SWL): a 
treatment protocol known to reduce SWL-induced renal injury. BJUI. May.2009 103:1270–1274.
13. Aoki Y, Ishitoya S, Okubo K, Okeda T, Maekawa S, Maeda H, et al. Changes in Resistive Index 
following Extracorporeal Shock Wave Lithotripsy. Int J Urol. Oct.1999 483–92:483–92.
14. Mohseni M, Khazaeli H, Aqhamir S, Biniaz F. Changes in intrarenal resistive index following 
electromagnetic extracorporeal shock wave lithotripsy. Urol J. Fall;2007 4:217. [PubMed: 
18270945] 
15. Janetschek G, Frauscher F, Knapp R, Hofle G, Peschel R, Bartsch G. New onset hypertension after 
extracorporeal shock wave lithotripsy: age related incidence and prediction by intrarenal resistive 
index. J Urol. Aug.1997 158:346–351. [PubMed: 9224300] 
16. Knapp R, Frauscher F, Helweg G, Judmaier W, Strasser H, Bartsch G, zur Nedden D. Blood 
pressure changes after extracorporeal shock wave nephrolithotripsy: prediction by intrarenal 
resistive index. Eur Radiol. May.1996 6:665–669. [PubMed: 8934132] 
17. Williams C, Kaude J, Newman R, Peterson J, Thomas W. Extracorporeal shock-wave lithotripsy: 
long-term complications. Am J Roentgenol. Feb.1988 150:311–315. [PubMed: 3257316] 
Bailey et al. Page 6
IEEE Int Ultrason Symp. Author manuscript; available in PMC 2015 July 20.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
Figure 1. 
Average RI index measured during the treatment procedure. Error bars represent standard 
deviation.
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Figure 2. 
Individual RI index measurements for all 15 subjects.
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TABLE I
Resistive Index (RI) and Blood Pressure Results duirng ESWL
Treatment Time RI* Systolic Blood Pressure* (mmHg) Diastolic Blood Pressure* (mmHg)
Pre-treatment 0.66 ± 0.06 123 ± 12 84 ± 8
250 Shocks 0.69 ± 0.08 89 ± 8 56 ± 7
750 Shocks 0.72 ± 0.07 93 ± 4 56 ± 5
1500 Shocks 0.73 ± 0.07 97 ± 10 59 ± 10
Post-Treatment 0.74 ± 0.06 115 ± 29 69 ± 16
*
Mean +/− standard deviation
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